Affordable Access

From balloon angioplasty to drug-eluting stents: revolution or evolution?

Authors
  • King, Spencer B 3rd
Type
Published Article
Journal
The American heart hospital journal
Publication Date
Jan 01, 2004
Volume
2
Issue
2
Pages
73–79
Identifiers
PMID: 15604847
Source
Medline
License
Unknown

Abstract

Drug-eluting stenting is part of the evolution of interventional cardiology that started with Gruentzig's introduction of balloon angioplasty in 1977. Numerous advances in interventional cardiology technique have occurred since that time, and drug-eluting stents hold promise for reducing the restenosis rate but as yet have not been shown to influence survival or freedom from myocardial infarction. The ability of stents to influence these hard end points will be tested against the most difficult patient subset for interventional cardiology: persons with diabetes mellitus and multivessel disease. As more data are accumulated, prudent selective use of drug-eluting stenting seems most appropriate.

Report this publication

Statistics

Seen <100 times